The FGG gene helps make the gamma part of fibrinogen, a blood protein that forms a stable clot after an injury. If this gene does not work properly, clots may form poorly or behave abnormally, which can lead to easy bruising, nosebleeds, heavy menstrual bleeding, or bleeding after surgery or childbirth. Some people with certain FGG variants can also have an increased chance of unwanted blood clots. Understanding this gene can help clarify why clotting problems sometimes run in families.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or to regulate activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Other genes mostly guide when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. For a deeper look at this topic, you can find more in the LearnHub.
Overview
FGGGene function
What if the gene works
The FGG gene helps make the gamma part of fibrinogen, a blood protein that forms clots. This helps stop bleeding after injury and supports normal wound healing.
Risk
What if the gene does not work
Variants in the FGG gene can disrupt blood clotting, leading to fibrinogen conditions with bleeding that ranges from mild bruising to severe bleeding. Some variants also increase the chance of abnormal clots or pregnancy loss.
Treatment
What does that mean for your treatment
Pathogenic variants in the FGG gene can make fibrinogen replacement a key part of care, especially for bleeding, surgery, or childbirth; purified fibrinogen concentrate is often preferred when available. Some FGG variants also raise the chance of blood clots, so anticoagulants may be used in selected situations. Medicines that increase clotting risk, including estrogen containing drugs, may need extra caution.
Conditions associated with FGG
Gene function
What if the gene works
When bleeding starts, your body needs the FGG gene to help form a firm blood clot. It provides instructions for the gamma part of fibrinogen, a blood protein made mainly in the liver. This is a core part of normal FGG gene function in blood clotting.
It helps create fibrinogen, which is changed into fibrin when a blood vessel is injured. Fibrin forms fine strands that make the basic framework of a clot.
The gamma part helps fibrin strands link together in an organized way. This gives a normal clot more strength and helps it stay in place while healing begins.
This part of fibrinogen also helps platelets, the blood cells that clump during bleeding, attach to the forming clot. That support helps seal an injured area more effectively.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Different FGG gene variants can change how the gamma part of fibrinogen is built, folded, or released into the blood. How variants in the FGG gene affect function ranges from milder changes that partly reduce protein stability to more severe variants that leave little or no usable protein. Some variants also disrupt how fibrin links together, and a few make the protein more likely to form amyloid (protein clumps), which may relate to earlier symptoms.
How variants are linked to conditions
Pathogenic variants in the FGG gene cause inherited fibrinogen disorders, including congenital afibrinogenemia, hypofibrinogenemia, and dysfibrinogenemia. In practical terms, the FGG gene is linked to bleeding and clotting disorders, and some people have easy bruising, nosebleeds, heavy menstrual bleeding, or blood clots, while others have few symptoms. A confirmed pathogenic variant in the FGG gene can help establish the diagnosis, alongside blood clotting test results.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common across the general population. Most do not have a direct effect on health and simply represent natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well understood variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For FGG, risk mainly depends on the specific gene change and whether one or both copies of the gene are affected. In people living with an FGG-related fibrinogen condition, bleeding or clotting problems can be more likely around surgery, injury, pregnancy, long periods of immobility, or with estrogen-containing medicines.
Inheritance of FGG variants
The inheritance of FGG-related conditions depends on the specific fibrinogen problem caused by the variant. FGG gene variants linked to congenital afibrinogenemia usually follow an autosomal recessive pattern, which means a child inherits one altered copy from each parent. Other FGG gene variants, especially those causing dysfibrinogenemia or low fibrinogen with abnormal function, can follow an autosomal dominant pattern, so an affected parent can pass it to a child with a 50% chance. This mixed pattern is the key to understanding how FGG gene variants are inherited in families.
What does my FGG result mean for my family?
For FGG, what it means for family members depends on the specific condition linked to the result. Some FGG-related conditions run in families in a dominant way, so a parent, child, brother, or sister may also carry the same change. Other FGG-related conditions are recessive, which means relatives may be healthy carriers without knowing it. Because FGG can follow more than one clear inheritance pattern, family implications are best understood in the context of the exact result.
Genetic information
Genetic testing
How you find out about variants
FGG genetic testing looks for variants in the FGG gene using a blood or saliva sample. A lab reads the gene's DNA sequence to check for changes that may help explain inherited fibrinogen conditions or unusual clotting or bleeding results. Results may show a known variant, no relevant variant, or a finding that needs more interpretation.
When should I consider getting a genetic test?
Consider testing for changes in the FGG gene if you or close family members have unusual bleeding, unexpected blood clots, repeated pregnancy loss, or blood tests showing low or abnormal fibrinogen, a protein that helps blood clot. It can also help clarify a family history of an inherited fibrinogen condition.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains varies with the condition and the kind of variant involved. Over time, many factors also shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, it can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person might work less well for another, or it may cause more side effects, because the body can absorb, break down, transport, or respond to a drug differently. These inherited differences are common and help explain part of the normal variation in medication response. Genetics is only one piece of the picture, alongside age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medications. By studying links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the FGG gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice, so questions about medicines, unusual bleeding or clotting, or your overall health are best discussed with your doctor.
History
Inherited patterns of unusual bleeding or unexpected blood clots were described long before the FGG gene was identified. In the 20th century, doctors began linking some of these family patterns to fibrinogen, a blood protein involved in clotting. Once considered rare, now recognized as an important part of human genetics, changes in the FGG gene were later found to explain some cases of inherited fibrinogen conditions. Building on this early work, scientists distinguished different forms, including low fibrinogen levels and fibrinogen that does not work as expected. As genetic testing became more available, the picture grew clearer for affected families. These historical steps shaped today’s understanding of how inherited FGG variants can be identified and classified.